OpenAlex
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
Work
Year: 2022
Type: article
Abstract: Therapeutic options targeting inflammation in multiple sclerosis (MS) have evolved rapidly for relapsing-remitting MS, whereas few therapies are available for progressive forms of MS, in particular se... more
Cites: 27
Cited by: 12
Related to: 10
FWCI: 2.703
Citation percentile (by year/subfield): 99.99
Field: Medicine
Sustainable Development Goal Good health and well-being
Open Access status: diamond